Literature DB >> 12575832

Ischemia and stroke.

Matthias Endres1, Ulrich Dirnagl.   

Abstract

Cell death following cerebral ischemia is mediated by a complex pathophysiologic interaction of different mechanisms. In this Chapter we will outline the basic principles as well as introduce in vitro and in vivo models of cerebral ischemia. Mechanistically, excitotoxicity, peri-infarct depolarization, inflammation and apoptosis seem to be the most relevant mediators of damage and are promising targets for neuroprotective strategies.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12575832     DOI： 10.1007/978-1-4615-0123-7_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  18 in total

Review 1.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

2.  Behavioural studies with a newly developed neuroprotective KYNA-amide.

Authors:  Levente Gellért; Dániel Varga; Marian Ruszka; József Toldi; Tamás Farkas; István Szatmári; Ferenc Fülöp; László Vécsei; Zsolt Kis
Journal:  J Neural Transm (Vienna)       Date:  2011-08-05       Impact factor: 3.575

Review 3.  Traumatic brain injury: can the consequences be stopped?

Authors:  Eugene Park; Joshua D Bell; Andrew J Baker
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

Review 4.  Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection.

Authors:  M Slevin; J Krupinski; P Kumar; J Gaffney; S Kumar
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

5.  MicroRNAs in Cerebral Ischemia.

Authors:  Kai-Ying Lim; Jia-Hui Chua; Jun-Rong Tan; Priyadharshni Swaminathan; Sugunavathi Sepramaniam; Arunmozhiarasi Armugam; Peter Tsun-Hon Wong; Kandiah Jeyaseelan
Journal:  Transl Stroke Res       Date:  2010-12       Impact factor: 6.829

6.  Spatial and temporal MRI profile of ischemic tissue after the acute stages of a permanent mouse model of stroke.

Authors:  A Bogaert-Buchmann; M Poittevin; C Po; D Dupont; C Sebrié; Y Tomita; A Trandinh; J Seylaz; E Pinard; P Méric; N Kubis; B Gillet
Journal:  Open Neuroimag J       Date:  2013-02-01

7.  Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.

Authors:  Johannes Boltze; Björn Nitzsche; Kathrin D Geiger; Heinz-Adolf Schoon
Journal:  Transl Stroke Res       Date:  2011-08-23       Impact factor: 6.829

8.  Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.

Authors:  Stephanie L H Zeiger; Erik S Musiek; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger J Milne; BethAnn McLaughlin
Journal:  Free Radic Biol Med       Date:  2009-08-19       Impact factor: 7.376

9.  PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.

Authors:  Sofiyan Saleem; Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2009-02-11       Impact factor: 3.911

10.  Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.

Authors:  Eun-Hee Kim; Aaron T Tolhurst; Hazel H Szeto; Sung-Hee Cho
Journal:  CNS Neurosci Ther       Date:  2014-09-12       Impact factor: 5.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.